Loading…
Lobbying Income
—
Filings
101
Unique Clients
1
Active Period
1999–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 1
Abortion is Health Care Everywhere Act of 2026
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 10600
Women’s Health Protection Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 12
Equal Access to Contraception for Veterans Act
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 211
MIDWIVES for Service Members Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 3202
Health Equity and Access under the Law for Immigrant Families Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 4104
Advancing Maternal Health Equity Under Medicaid Act
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 4150
Saving Lives and Taxpayer Dollars Act
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 4516
EACH Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 4611
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 5202
To provide low-income individuals with opportunities to enter and follow a career pathway in the health professions, and for other purposes.
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 5370
FACE Act Repeal Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 589
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 6238
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 7973
Perinatal Workforce Act
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 8089
Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes.
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 8469
Department of Defense Appropriations Act, 2027
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 9495
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 9712
Fertility Cost Relief Act
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 9753
State Offices of Women’s Health Support and Expansion Act
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 9842
Right to IVF Act of 2026
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.R. 9941
Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care.
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: H.Res. 1389
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: S. 1598
Health Equity and Access under the Law for Immigrant Families Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: S. 2149
Women’s Health Protection Act of 2025
2026 · third_quarter · Client: CENTER FOR REPRODUCTIVE RIGHTS
Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 4516 / S. 2252, Saving Lives and Taxpayer Dollars Act H.R. 5202 / S. 1598, BABIES Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 5370 / S. 5296, Pathways to Health Careers Act H.R. 6238 / S. 3254, NIH IMPROVE Act H.R. 9712 / S. 4986, Mamas First Act H.R. 9941 / S. 5108, Right to IVF Act of 2026 H.R. 3202, MIDWIVES for Service Members Act of 2025 H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act H.R. 9842, State Offices of Womens Health Support and Expansion Act H.R. 10600, Abortion is Health Care Everywhere Act of 2026 H.R. 9753, Fertility Cost Relief Act H.R. 211, Equal Access to Contraception for Veterans Act H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act S. 3097, Health Information Privacy Reform Act Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing language titled Reproductive Health Services in Title II of the report accompanying the bill regarding the funding for abortion care for veterans. H.R. 9495, Making appropriations for the Department of Defense for the fiscal year ending September 30, 2027, and for other purposes. Section 8153 prohibiting the use of human fetal tissue for research if the tissue is obtained pursuant to an abortion. Section 8158 prohibiting the use of government funds for servicemembers to travel for abortion care. Opposing all provisions in the following legislation or administrative actions: H.R. 589, FACE Act Repeal Act of 2025 "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act. Opposing the nomination of: Todd Blanche, Attorney General, PN1078 Heidi Overton, Commissioner of the Food and Drug Administration (FDA), PN1273-17
Client expense: $50,000 · Firm income: —
Matched citations: S. 2150
Source: Senate LDA